T-BOOH INDUCED DNA DAMAGE: PROTECTION BY GLYCOPROTEIN BGS-HARIDRIN FROM TURMERIC (CURCUMA LONGA)
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.2, No. 7)Publication Date: 2015-08-24
Authors : Dinesha R; Leela Srinivas;
Page : 1114-1118
Keywords : Reactive oxygen species; DNA damage; Dietary antioxidant; lymphocytes; t-BOOH; BGS-Haridrin; Curcumin;
Abstract
The main objective of the study is to find a non toxic dietary spice towards preventing oxidative DNA damage induced by t-BOOH. Standard antioxidant Butylated Hydroxy Anisole, Curcumin, BGS-Haridrin, Tertiary butyl hydroperoxide, calf thymus DNA, Tryphan blue. The sheared DNA was used in submarine agarose gel electrophoresis where DNA damage was induced by using tertiary butyl hydroperoxide. Similarly, the cytotoxicity study was also done using Tryphan blue to know that the antioxidant itself is not toxic to cells by using lymphocytes isolated from fresh human blood. The submarine gel electrophoresis bands were visualized in Transilluminator where, it was confirmed that, tertiary butyl hydroperoxide induced DNA damaged was successfully prevented by BHA (400?M), Curcumin (400?M) and BGS-Haridrin (0.1?M). In cell cytotoxicity studies, Curcumin, alpha-tocopherol and BGS-Haridrin inhibits the cell damage 55%, 63% and 68% respectively. The results confirm that, BGS-Haridrin extract can inhibit tertiary butyl hydroperoxide induced DNA damage and is nontoxic to cells. Keywords: Reactive oxygen species, DNA damage, Dietary antioxidant, lymphocytes, t-BOOH, BGS-Haridrin, Curcumin
Other Latest Articles
- CHAMAECOSTUS CUSPIDATUS ? A SHORT REVIEW ON ANTI DIABETIC PLANT
- STANDARDIZATION, FORMULATION AND EVALUATION OF COX-2 INHIBITOR FORMULATION IN SEMISOLID DOSAGE FORM SUITABLE FOR USE IN MUSCULOSKELETAL DISORDERS
- DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 4- (2,3-DIHYDRO-4H-PYRIDO[3,2-B][1,4]OXAZIN-4-YL)-3- FLUOROANILINE DERIVATIVES
- A STUDY ON PREVALENCE AND RISK FACTORS ASSOCIATED WITH HYPERTENSION IN DIABETES MELLITUS BY USING POISSON REGRESSION MODEL
- FREQUENCY AND REASON FOR DRUGS RETURNED BACK TO PHARMACY
Last modified: 2015-08-24 02:02:48